Assistant Professor, Surgery, UCSF
| CONTACT | |
|
(415) 353-9888 (appts) Box 1932, UCSF; San Francisco, CA 94143-1932 |
additional websites: |
| EDUCATION | |
|
University of California, San Diego, La Jolla, CA , BS, 1990, Bioengineering-Premedic
|
|
| PROFESSIONAL EXPERIENCE | |
|
1995-1996 |
Intern, General Surgery, Johns Hopkins Medical Institutions, Baltimore, MD |
|
1996-2003 |
Resident, General Surgery, Johns Hopkins Medical Institutions, Baltimore, MD |
|
2003-2004 |
Fellow, Surgical Oncology, Johns Hopkins Medical Institutions, Baltimore, MD |
|
2003-2004 |
Assistant Chief of Service/Instructor, General Surgery, Johns Hopkins Medical Institutions |
|
2004-present |
Assistant Professor, Department of Surgery, University of California, San Francisco |
| HONORS & AWARDS | |
|
1988 |
Phi Beta Kappa, University of California, San Diego |
|
1990 |
Magna Cum Laude, University of California, San Diego |
|
1991 |
Stanford Medical Student Scholars Program Research Fellow |
|
1992 |
International Society for Heart and Lung Transplantation Poster Award Recipient |
|
1992 |
American Heart Association Medical Student Research Fellow |
|
2000 |
George D. Zuidema Award for Laboratory Research, Department of Surgery, Johns Hopkins Medical Institutions |
|
2003 |
John L. Cameron Technical Excellence Award, Department of Surgery, Johns Hopkins Medical Institutions |
|
2007 |
Excellence in Teaching Award, Department of Surgery, University of California, San Francisco School of Medicine |
| SELECTED PUBLICATIONS | |
|
Nakakura EK, McCabe SM, Zheng B, Shorthouse RA, Scheiner TM, Blank G, Jardieu PM, Morris RE. Potent and effective prolongation by anti-LFA-1 monoclonal antibody monotherapy of non-primarily vascularized heart allograft survival in mice without T cell depletion. Transplantation. 1993 Feb;55(2):412-17. | |
|
Nakakura EK, McCabe SM, Zheng B, Shorthouse RA, Scheiner TM, Blank G, Jardieu PM, Morris RE. A non-lymphocyte-depleting monoclonal antibody to the adhesion molecule LFA-1 (CD11a) prevents sensitization to alloantigens and effectively prolongs the survival of heart allografts. Transplant Proc. 1993 Feb;25(1 Pt 1):809-12. | |
|
Nakakura EK, Shorthouse RA, Zheng B, McCabe SM, Jardieu PM, Morris RE. Long-term survival of solid organ allografts by brief anti-lymphocyte function-associated antigen-1 monoclonal antibody monotherapy.Transplantation. 1996 Sep 15;62(5):547-52. | |
|
Nakakura EK and Choti MA. Hepatocellular carcinoma: Current management recommendations. Advances in Oncology. 2000 June; 16(2): 12-18. | |
|
Nakakura EK, Choti MA. Management of hepatocellular carcinoma. Oncology (Huntingt). 2000 Jul;14(7):1085-98; discussion 1098-102. Review. | |
|
Nakakura EK, Watkins DN, Schuebel KE, Sriuranpong V, Borges MW, Nelkin BD, Ball DW. Mammalian Scratch: a neural-specific Snail family transcriptional repressor. Proc Natl Acad Sci U S A. 2001 Mar 27;98(7):4010-5. | |
|
Nakakura EK, Watkins DN, Sriuranpong V, Borges MW, Nelkin BD, Ball DW. Mammalian Scratch participates in neuronal differentiation in P19 embryonal carcinoma cells. Brain Res Mol Brain Res. 2001 Nov 1;95(1-2):162-6. | |
|
Sriuranpong V, Borges MW, Strock CL, Nakakura EK, Watkins DN, Blaumueller CM, Nelkin BD, Ball DW.Notch signaling induces rapid degradation of achaete-scute homolog 1. Mol Cell Biol. 2002 May;22(9):3129-39. | |
|
Nakakura EK, Sriuranpong VR, Kunnimalaiyaan M, Hsiao EC, Schuebel KE, Borges MW, Jin N, Collins BJ, Nelkin BD, Chen H, Ball DW. Regulation of Neuroendocrine Differentiation in Gastrointestinal Carcinoid Tumor Cells by Notch Signaling. J Clin Endocrinol Metab. 2005 July;90(7):4350-6. | |
|
Strock CJ, Park JI, Nakakura EK, Bova GS, Isaacs JT, Ball DW, Nelkin BD. Cyclin-dependent kinase 5 activity controls cell motility and metastatic potential of prostate cancer cells. Cancer Res. 2006 Aug 1;66(15):7509-15. |
|
|
Nakakura EK, Yeo CY. Periampullary and Pancreatic Cancer. In: Blumgart LH (ed.), Surgery of the Liver, Biliary Tract, and Pancreas, 4th ed., Elsevier Inc., 2007: 849-57. |
|
|
Nakakura EK, Bergsland EK. Islet cell carcinoma: neuroendocrine tumors of the pancreas and periampullary region. Hematol Oncol Clin North Am. 2007 Jun;21(3):457-73. |
|
|
Nakakura EK, Venook AP, Bergsland EK. Systemic and regional nonsurgical therapy-what is the optimal strategy for metastatic neuroendocrine cancer? Surg Oncol Clin N Am. 2007 Jul;16(3):639-51. |
|
|
Nakakura EK, Warren RS Palliative care for patients with advanced pancreatic and biliary cancers. Surg Oncol., Sep/11/2007. |
|
|
Tempero M, Arnoletti JP, Ben-Josef E, Bhargava P, Casper ES, Kim P, Malafa MP, Nakakura EK, Shibata S, Talamonti M, Wang H, Willett C Pancreatic adenocarcinoma. Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 5: 998-1033, Nov/2007. |
|
|
Sperti C, Nakakura E, Duncan M, Eckhauser F. Distal pancreatectomy, First Ed. Editor(s): Clavien P. Atlas of Upper Gastrointestinal and Hepato-Pancreato-Biliary Surgery: Springer, 2007. |
|
|
Horvai AE, Schaefer JT, Nakakura EK, O'Donnell RJ. Immunostaining for peroxisome proliferator gamma distinguishes dedifferentiated liposarcoma from other retroperitoneal sarcomas. Mod Pathol, Jan/18/2008. |
|
|
Guo L, Clark JP, Warren RS, Nakakura EK. Compound muscle action potentials and spontaneous electromyography can be used to identify and protect the femoral nerve during resection of large retroperitoneal tumors. Ann Surg Oncol, Jun/2008;15(6):1594-9. |
|
|
Logan SL, Nakakura EK. Locoregional alternatives to liver resection: Ablation, intraarterial therapy, and radiation therapy. Editor(s): Marshall JL, Choti MA. Managing colorectal cancer: The resectable and potentially resectable patient--A multidisciplinary approach: CMPMedica, 2008. |
|
|
Wang YC, Gallego-Arteche E, Iezza G, Yuan X, Matli M, Choo SP, Zuraek M, Gogia R, Lynn F, German M, Bergsland E, Donner D, Warren R, Nakakura E. Homeodomain transcription factor Nkx2.2 functions in immature cells to control enteroendocrine differentiation and is expressed in gastrointestinal neuroendocrine tumors. Endocr Relat Cancer, Nov/5/2008. |
|
|
11/13/08 |
|